Journal of Bone Oncology

Papers
(The TQCC of Journal of Bone Oncology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Senescence in the bone marrow microenvironment: A driver in development of therapy-related myeloid neoplasms133
#15. Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma52
Postoperative outcomes of subaxial cervical spine metastasis: Comparison among the anterior, posterior, and combined approaches51
Single Photon Emission Computed Tomography/X-ray Computed Tomography-based radiomics analysis for diagnosis of bone metastases in patients with breast cancer31
From bimodal to unimodal: The transformed incidence of osteosarcoma in the United States27
Macrophage heterogeneity in bone metastasis24
MAT2A inhibits the ferroptosis in osteosarcoma progression regulated by miR-26b-5p23
Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw22
Lipid metabolic reprogramming and associated ferroptosis in osteosarcoma: From molecular mechanisms to potential targets20
Demethylzeylasteral inhibits proliferation and metastasis of osteosarcoma cells by modulating the PI3K/AKT/Autophagy pathways20
Radiomics model based on MRI to differentiate spinal multiple myeloma from metastases: A two-center study20
A multicenter, randomized, double-blind trial comparing LY01011, a biosimilar, with denosumab (Xgeva®) in patients with bone metastasis from solid tumors19
State-of-the-art of minimally invasive treatments of bone metastases19
Rotationplasty performed in adults versus minors: a comparative study of long-term quality of life, functional and biomechanical outcomes19
Predicting lung metastasis in high-grade osteosarcoma: The role of computed tomography angiography (CTA) signs with a focus on vascular wrapping and the intratumoral vascular network19
Targeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancer17
Preoperative prediction of high-grade osteosarcoma response to neoadjuvant therapy based on a plain CT radiomics model: A dual-center study17
Comprehensive landscape of TGFβ-related signature in osteosarcoma for predicting prognosis, immune characteristics, and therapeutic response16
#1. Acid ceramidase (ASAH1) is a key mediator of drug resistance in relapsed/refractory multiple myeloma16
Association of androgen receptor and tumour-infiltrating lymphocytes with bone recurrence in triple-negative breast cancer16
#41. Discovery of novel tubulin code in bone metastasis of breast cancer16
#31. A Phase I/II trial of ATI-2231 with Phase Ia in advanced soild tumor malignancies followed by Phase Ib/II in combination with capecitabine in patients with hormone receptor-positive (HR+) and HER15
Pain in patients with multiple inherited osteochondromas: Incidence and potential prognostic factors. A retrospective cohort study15
#6. Mechanical loading of breast cancer laden bones alters osteocyte mediated bone loss in vivo15
#23. Elucidating the role of bone marrow stiffness in estrogen signaling in metastatic breast cancer to the bone14
Intraosseous conventional central chondrosarcoma does not metastasise irrespective of grade in pelvis, scapula and in long bone locations14
#49. Complete estrogen-deprived athymic nude mice are susceptible to changes in metabolism and musculoskeletal function mediated by a high-fat diet14
#2. Homing of intestinal NK and Th1 cells to the tumor site restrains melanoma bone growth in a gut microbiome dependent manner14
Long-term oncological and functional outcomes in patients with bone sarcomas in the proximal femur undergoing unplanned surgery: A single-center retrospective cohort study13
Zoledronic acid in metastatic castrate-sensitive prostate cancer: A state-of-the-art review13
Impact of myosteatosis on prognosis in multiple myeloma patients: A subgroup analysis of 182 cases and development of a nomogram13
#14. Determining how prostate cancer cell heterogeneity promotes bone metastasis using fluid-walled microfluidics13
FemurTumorNet: Bone tumor classification in the proximal femur using DenseNet model based on radiographs13
Targeting stromal p38MAPKalpha triggers innate-adaptive anti-tumor immunity and sensitizes metastatic breast cancer to immunotherapy13
LncRNA SATB2-AS1 promotes tumor growth and metastasis and affects the tumor immune microenvironment in osteosarcoma by regulating SATB213
Molecular imaging of bone metastasis12
Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms12
Incidence and radiotherapy treatment patterns of complicated bone metastases12
#50. Investigating the role of EphA2 in breast cancer bone metastasis12
Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma12
The roles of the FL/FLT3 axis in the development of cancer-induced bone pain mediated by prostate cancer12
#8. Radium-223 treated primary patient bone biopsy analysis: Macro to microscale analyses and dosimetry11
Latest developments in the pathobiology of Ewing sarcoma11
#51. High dimensional profiling of human prostate metastatic bone marrow microenvironment using mass cytometry11
Multicenter study on atypical femoral fractures in patients with bone metastases taking bone- modifying agents11
Health- related quality of life after surgery for spinal metastases10
Giant cell tumor of bone: A single center study of 115 cases10
Mixed reality infrastructure based on deep learning medical image segmentation and 3D visualization for bone tumors using DCU-Net10
The impact of comprehensive local therapy on treatment outcomes of non-small cell lung cancer with solitary skeletal oligometastasis10
Bone metastasis in colorectal cancer: Pathophysiology, prognostic factors, survival outcomes, and treatment strategies – A comprehensive review9
YBX1-interacting small RNAs and RUNX2 can be blocked in primary bone cancer using CADD5229
COPB2 as a key regulator of cell growth in human osteosarcoma cells: Potential therapeutic target and prognostic indicator9
#7. Downstream effects of Gli2 targeting on tumor-immune cell crosstalk in bone metastatic breast cancer9
Treatment of myeloma bone disease: When, how often, and for how long?9
Bones and guts – Why the microbiome matters9
Circ_0051079 silencing inhibits the malignant phenotypes of osteosarcoma cells by the TRIM66/Wnt/β-catenin pathway in a miR-625-5p-dependent manner9
#45. Fatty acid binding proteins may modulate myeloma in Fabp4/5 double knockout mouse9
Molecular pathological insights into tumorigenesis and progression of giant cell tumor of bone9
Automatic classification of spinal osteosarcoma and giant cell tumor of bone using optimized DenseNet9
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of WHO fracture risk assessment tool (FRAX) and bone mineral density in real-life clinical pr9
Pexmetinib suppresses osteoclast formation and breast cancer induced osteolysis via P38/STAT3 signal pathway8
Does liquid nitrogen recycled autograft for treatment of bone sarcoma impact local recurrence rate? A systematic review8
The metastatic role of the CXCL10-CXCR3 axis and its therapeutic potential in osteosarcoma8
Yin Yang 1 protein-activated N-acetyltransferase 10 drives cell malignant progression of osteosarcoma through ac4C acetylation of integrin β38
Deep hashing and attention mechanism-based image retrieval of osteosarcoma scans for diagnosis of bone cancer8
Luteolin attenuates the chemoresistance of osteosarcoma through inhibiting the PTN/β-catenin/MDR1 signaling axis by upregulating miR-3848
A novel adjunctive diagnostic method for bone cancer: Osteosarcoma cell segmentation based on Twin Swin Transformer with multi-scale feature fusion8
Diagnostic value of H3F3A mutation and clinicopathological features of giant cell tumours in non-long bones8
Osteofibrous dysplasia, osteofibrous Dysplasia-Like adamantinoma, and adamantinoma: A Single-center retrospective analysis7
Determinants of tumor necrosis and its impact on outcome in patients with Localized osteosarcoma uniformly treated with a response adapted regimen without high dose Methotrexate– A retrospective insti7
RGS1 stabilized by METTL3-mediated m6A modification promotes the tumorigenicity and macrophage M2 polarization in osteosarcoma7
Multimodal deep learning for bone tumor diagnosis with clinical imaging, pathology, and blood biomarkers7
Diagnosis of newly developed multiple myeloma without bone disease detectable on conventional computed tomography (CT) scan by using dual-energy CT7
Malignant and metastatic giant cell tumors of bone; clinical course of primary or secondary malignant and pulmonary metastatic variants7
Surgical Options for Aggressive Vertebral Hemangiomas：A case series, literature review and treatment recommendations7
Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study7
Auxiliary diagnosis of primary bone tumors based on Machine learning model7
Non-POEMS osteosclerotic multiple myeloma: Clinical characteristics and differential diagnosis7
Cav3.2 T-Type calcium channels downregulation attenuates bone cancer pain induced by inhibiting IGF-1/HIF-1α signaling pathway in the rat spinal cord7
Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival6
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma6
An enhanced AlexNet-Based model for femoral bone tumor classification and diagnosis using magnetic resonance imaging6
Radiographic imaging and diagnosis of spinal bone tumors: AlexNet and ResNet for the classification of tumor malignancy6
Groenlandicine enhances cisplatin sensitivity in cisplatin-resistant osteosarcoma cells through the BAX/Bcl-2/Caspase-9/Caspase-3 pathway6
The role of IL-1B in breast cancer bone metastasis6
0.12038207054138